发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 295 |
| Italy | 117 |
| Canada | 77 |
| GERMANY (FED REP GER) | 68 |
| France | 52 |
| Japan | 49 |
| Austria | 41 |
| CHINA MAINLAND | 30 |
| England | 29 |
| South Korea | 20 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF TEXAS SYSTEM | 50 |
| HARVARD UNIVERSITY | 49 |
| MEDICAL UNIVERSITY OF VIENNA | 38 |
| DANA-FARBER CANCER INSTITUTE | 37 |
| UNIVERSITY OF HAMBURG | 35 |
| UNIVERSITY OF MONTREAL | 34 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 33 |
| VITA-SALUTE SAN RAFFAELE UNIVERSITY | 32 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 31 |
| CLEVELAND CLINIC FOUNDATION | 27 |
文章引用情况
1
Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study2
Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer3
Transperineal Magnetic Resonance Imaginge-Targeted Biopsy May Perform Better Than Transrectal Route in the Detection of Clinically Significant Prostate Cancer: Systematic Review and Meta-analysis4
Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting5
The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy6
Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+Year Population-level Analysis7
Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors8
Disparities in Access and Regionalization of Care in Testicular Cancer9
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature10
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature